Duaer

Guides

Pharmacovigilance AI Course 2027: Choosing Your First Use Case

Drawn from the Duaer docs, this article explains how pharmacovigilance (PV) teams can choose their first AI pilot after an AI course, covering workflow breakdown, value and difficulty ranking, pilot selection, course design, and outcome measurement.

Start with the real pharmacovigilance workflows, then choose the course

Most teams that sign up for a pharmacovigilance AI course want the same outcome: safety operations that run faster and more consistently, without putting patient safety at risk. The course itself is rarely the bottleneck. The harder problem is that pharmacovigilance (PV) is a chain of regulated tasks, and a general AI course will not tell you where to start. Teams often finish training with plenty of model concepts in mind, then return to work still unsure whether to automate case intake, literature screening, or signal evaluation first. Without that decision, training stays abstract and the work stays manual.

PV work is not one task. In most organizations it breaks down into several recurring workflows: individual case safety report (ICSR) intake and processing, medical coding of adverse event terms, literature monitoring, signal detection and evaluation, and periodic safety reporting. Each has different inputs, different owners, and different regulatory requirements.

Case intake usually means receiving reports from call centers, healthcare professionals, patients, partners, and published literature, then extracting structured fields such as the suspect product, event description, dates, and reporter qualification. Duplicate case detection is closely related, since the same case often arrives through several channels. Literature monitoring means scanning publications and databases for relevant safety information and screening it against defined criteria. Signal management means looking across many cases over time to find patterns worth closer review. Periodic reporting means assembling aggregated safety data into documents submitted to regulators on a fixed schedule.

For your team, a useful course explains these workflows in the context of your own operations, not just AI in general. If the content cannot be mapped to these specific tasks, it becomes hard to measure whether people have learned anything that changes their daily work.

Rank the workflows by value and difficulty

Once the workflows are clear, you can rank them along two dimensions. The value dimension asks how much staff time, backlog, or delay the task currently creates. The difficulty dimension asks how heavily the task depends on clean data, explicit rules, and a low tolerance for error.

Across many PV functions, a rough pattern tends to appear. Literature screening often has high value and moderate difficulty, because the input is text, the screening criteria can be written down, and a human reviewer still makes the final decision. Information extraction in case intake is also high value, but harder, because source documents vary widely in format and language, and field-level errors can carry regulatory consequences. Signal detection is valuable but among the most difficult, because it requires reliable historical data, careful statistical methods, and strict governance over how signals are escalated. Drafting periodic reports helps with assembling existing outputs, but it depends heavily on the quality of the underlying case data.

It helps to capture this in a simple table listing each workflow, current volume, average handling time, consequence of error, data readiness, and who must sign off. The table is not a precise model. Its purpose is to make the trade-offs visible so the team is not arguing from enthusiasm alone.

Pick a first pilot that teaches you something without exposing you to unnecessary risk

A first pilot should meet three conditions. First, it should occur often enough to produce results within weeks rather than quarters. Second, its output should be reviewed by a qualified person before it moves downstream. Third, its failures should be visible and inexpensive to contain.

Literature screening usually fits these conditions better than other workflows. The pilot can run alongside the existing process: the AI suggests relevance decisions, reviewers check them, and the team can compare agreement rates on a defined sample. Once the team has a habit of measuring extraction accuracy field by field, case intake can become a second pilot.

Avoid starting with signal detection, even though it looks like the most impressive application. It depends on data and governance structures that most teams are still building. Starting there often produces a demonstration rather than a workflow you can run.

Design the course around that pilot

If you are choosing or designing a course, ask the provider how the content will apply to the pilot you have selected. Focus on a few points: whether there are exercises using anonymized or synthetic examples from workflows like yours, whether there is clear guidance on human review and documentation, and whether there is a plan to measure whether the skills show up in day-to-day practice. If a course teaches the same material to everyone regardless of role, reviewers and case processors usually do not get the specific checkpoints they need.

Training must also reach leadership. Many PV heads will be asked to approve AI-assisted steps they do not fully understand. A short module explaining how to read error rates, when issues should be escalated, and what the audit trail must show is often more useful than a general introduction to machine learning.

Measure whether the course actually changed the work

Define your metrics before the course begins. Common ones include the time from receipt of a case to completed triage, the rate at which reviewers correct AI-suggested outputs, the share of literature items screened within the agreed timeline, and the number of documentation gaps found in internal audits. Track these weekly during the pilot.

Be wary of a common trap: rising training hours do not prove that the process has improved. If reviewers are still re-entering the same fields or working around the tool, the course has not taken hold. Conversely, a pilot that runs very fast but leaves no record of human review is a compliance risk, not a success.

To move from planning to practice, Duaer lets teams set up this kind of pilot workflow directly: define the use case, route outputs to reviewers, record corrections, and test training and process against the same data. Teams can sign up at https://www.duaer.com and try the workflow on a single PV process before deciding how far to expand.

Where to start this week

This week, pull the last three months of safety case intake data and tally the hours your team spends on each type of work. Place literature screening, case intake, and coding in the same table, with an added column showing how often each category of output is corrected. The workflow with high volume and manageable error cost is your candidate for the first pilot. When you choose a course, pick one that teaches that specific workflow rather than a generic syllabus.

If you want to turn this table into a rollout plan, you can sign up at https://www.duaer.com and try the workflow yourself. Our team can also work through your specific use cases with you.

Tell us about your use case and we will send back a written rollout path.

https://api.duaer.com/form/c59a907a-3697-4edf-a04d-3ea0fb72fdc8

Questions

What should I look for when choosing a pharmacovigilance AI course?

Focus on whether the course maps to your own workflows, such as case intake, literature screening, or signal evaluation. Look for practice exercises that use anonymized or synthetic examples, clear coverage of human review and documentation requirements, and a plan to measure whether the skills show up in daily work. Leadership should also receive training.

Which pharmacovigilance task is best suited as a first AI pilot?

Literature screening is usually the best starting point. Its input is text, the screening criteria can be written explicitly, a human reviewer makes the final decision, and it occurs often enough to show results quickly, while failures are easy to spot and relatively inexpensive to contain. Case intake can be the second pilot. Signal detection is tempting, but it depends on data and governance foundations that are more complex, so it is generally not a good first pilot.

How can I tell whether AI training has actually changed pharmacovigilance work?

Do not rely on training hours alone. Define metrics before the course starts and track them weekly during the pilot. Useful measures include the time from receipt of a case to completed triage, the rate at which reviewers correct AI outputs, the share of literature screening completed on time, and the documentation gaps found in audits. If reviewers are still re-entering data or bypassing the tool, the training has not taken hold.